Logo Soluventis

Advancing Oligonucleotide Therapeutics

KEY ADVISORS

Razelle Kurzrock, MD

Head of Center for Personalized Cancer Therapy at the Moores Cancer Center, University of California, San Diego, Principal Investigator on > 90 clinical trials and has overseen > 300 trials, developed clinical trail program at the MD Anderson Cancer Center, Houston, Texas

Ulrich Granzer, PhD

Founded Granzer Regulatory Consulting, > 150 international clients of SME and large pharma, expert in orphan drug applications, held senior positions on Regulatory Affairs in Big Pharma companies

Armin K. Bohmann, PhD

Founder of law firm Bohmann, specialized in biopharmaceutical IP, was leading head in the big court cases successfully eliminating the blocking patents in the field of oligonucleotides, network in>120 countries, regular lecturer on IP matters in the US, Japan and Germany

Jay Stoudemire, Ph.D.

FDA Panel Advisor, > 25 years of expertise in developing novel drug candidates and supporting nonclinical evaluation of drug candidates, held senior positions in several large pharma companies

Mark Benedyk, Ph.D.

Advisor to "RARE Science" focused on accelerating cures for children with rare diseases, previous Head of Pfizer's incubator for early stage companies, evaluated several drug delivery approaches

Dan Zekzer, MD / PhD

Technology scout at Daiichi Sankyo and Novo Nordisk, Immunologist, MD from Yale and PhD from the University of California, Los Angeles (UCLA), lecturer at UCLA, Founder of "Match Discovery", San Diego